Sherry Bullens,Stuart Bunting,Tianwei Chou,Augustus O Okhamafe,Christopher P. Price,Daniel J. Wendt,Clarence Yap
申请号：
US16837910
公开号：
US20200246434A1
申请日:
2020.04.01
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present disclosure provides for use of variants of C-type natriuretic peptide (CNP), and novel pharmaceutical compositions and formulations comprising CNP variant peptides for the treatment of skeletal dysplasias, one or more symptoms of skeletal dysplasias, such as long bone growth or growth velocity, and other disorders having a skeletal dysplasia and/or CNP-associated symptom or component.
